Orient Pharma Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 116.321 million compared to TWD 92.596 million a year ago. Net loss was TWD 23.617 million compared to TWD 38.262 million a year ago. Basic loss per share from continuing operations was TWD 0.13 compared to TWD 0.24 a year ago. For the nine months, sales was TWD 283.574 million compared to TWD 225.417 million a year ago. Net loss was TWD 83.556 million compared to TWD 122.383 million a year ago. Basic loss per share from continuing operations was TWD 0.51 compared to TWD 0.78 a year ago.